Future work is needed to more precisely estimate the differential effects of sex, disease stage, and NfL concentrations on clinical trajectories among genetic variants of FTD, particularly given the small sample size of participants within each of these stratified groups. The gene discussed is NEFL; the disease is frontotemporal dementia.